Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment for people with type 2 diabetes in England: A cross-sectional study.

Patrick BidulkaRohini MathurDavid G Lugo-PalaciosStephen O'NeillAnirban BasuRichard J SilverwoodPaul CharltonAndrew BriggsLiam SmeethAmanda I AdlerIan J DouglasKamlesh Khunti F MedSciRichard Grieve

Published in: Diabetes, obesity & metabolism (2022)

Among people with T2DM, there were no substantial differences by ethnicity or deprivation level in the percentage prescribed either SGLT2 inhibitors, DPP-4 inhibitors or SUs as second-line antidiabetic treatment.

Keyphrases

physical activity
type diabetes
adipose tissue
skeletal muscle
weight loss
affordable care act